Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > BLUE bluebird bio > Detailed Quotes

BLUE bluebird bio

Watchlist
6.380
+0.030+0.47%
Close  02/01 16:00 ET
6.390
+0.010+0.16%
Post Mkt Price 02/01 19:15 ET
High
6.480
Open
6.340
Turnover
18.27M
Low
6.140
Pre Close
6.350
Volume
2.90M
Market Cap
529.05M
P/E(TTM)
Loss
52wk High
8.580
Shares
82.92M
P/E(Static)
Loss
52wk Low
2.865
Float Cap
483.94M
Bid/Ask %
0.00%
Historical High
152.883
Shs Float
75.85M
Volume Ratio
0.99
Historical Low
2.865
Dividend TTM
--
Div Yield TTM
--
P/B
3.33
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.82%
Amplitude
5.35%
Avg Price
6.310
Lot Size
1
Float Cap
483.94M
Bid/Ask %
0.00%
Historical High
152.883
Shs Float
75.85M
Volume Ratio
0.99
Historical Low
2.865
Dividend TTM
--
P/B
3.33
Dividend LFY
--
Turnover Ratio
3.82%
Amplitude
5.35%
Avg Price
6.310
Lot Size
1
Price Forecast

News

Comment

Company Overview More
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Its integrated product platform includes gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
CEO: Mr. Andrew Obenshain
Market: NASDAQ
Listing Date: 06/19/2013
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist